Molecular Partners Ag MOLN
NASDAQ MOLN
$4.40 +0.17 (+4.04%)
As of: Aug 21, 2026 · 12:43 PM EDT

Molecular Partners Ag (MOLN) EBT Margin (QoQ) (2020 - 2026)

Molecular Partners Ag (MOLN) EBT Margin (QoQ) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Molecular Partners Ag 163.99 Mn 163.99 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.40 Mn
Dec 31, 2025 14.40 Mn
Sep 30, 2025 1,953.00
Jun 30, 2025 -1,389.00
Mar 31, 2025 -109.77 Mn
Dec 31, 2024 109.76 Mn
Sep 30, 2024 97.24 Mn
Jun 30, 2024 -97.20 Mn
Mar 31, 2024 49,555.00
Dec 31, 2023 -45,899.00
Sep 30, 2023 340,211.00
Jun 30, 2023 -385,229.00
Mar 31, 2023 -8,213.00
Dec 31, 2022 8,213.00
Sep 30, 2022 3,846.00
Jun 30, 2022 -3,846.00
Mar 31, 2022 -80.00
Dec 31, 2021 34,920.00
Sep 30, 2021 -35,183.00
Jun 30, 2021 344.00